With New Scrutiny, Life Sci Startups Become Risky Targets

Law360, New York (October 26, 2017, 5:07 PM EDT) -- In a recent article, Law360 interviewed top federal health care prosecutors who identified an emerging enforcement trend: focusing on startups and other smaller life sciences companies. If this proves to be an enduring trend, it could have a big impact on the industry. Smaller companies could be forced to put more focus on compliance at an earlier stage — and larger companies may be more concerned about enforcement risk when shopping for acquisition targets, even as smaller companies remain a vital pipeline for innovation in the industry.

As total settlements and judgments in federal health care fraud cases have more than...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS